Humana Inc. is committed to helping their millions of medical and specialty members achieve their best health. Their successful history in care delivery and health plan administration is helping them create a new kind of integrated care with the power to improve health and well-being and lower costs. Their efforts are leading to a better quality of life for people with Medicare, families, individuals, military service personnel, and communities at large.
Industry sector: Medical
Sector classification: Hospital & medical service plans
Deep Learning based analysis and prediction model for Humana Inc. (HUM) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.
Model is in the production pipeline since Sept. 30, 2015.
Market data for HUM model training are being downloaded from the
Quandl premium datasets on a daily basis.
Risks related to the novel coronavirus disease 2019 (COVID-19) caused by the virus named “SARS-CoV-2” are
accounted for in this model in the form of the historical data coincided with outbreaks and other
global events in the past used to train ML prediction model for HUM.
Model is being retrained on a daily basis.
| Float | 137M |
| P/E | 23.39 |
| Shares Outstanding | 138M |
| % Held by Insiders | 0.60% |
| % Held by Institutions | 96.61% |
| EPS (last reported FY) | $11.71 |
| EPS (last reported Q) | $3.36 |
| EPS, estimated (last reported Q) | $3.21 |
| Total revenues | $54 B |
| Net income | $2 B |